Please use this identifier to cite or link to this item: http://hdl.handle.net/10553/6534
Title: Does recombinant human Epo increase exercise capacity by means other than augmenting oxygen transport?
Authors: Lundby, Carsten
Robach, Paul
Boushel, R.
Thomsen, J.
Rasmussen, Peter
Koskolou, Maria D.
Calbet, J. A. L. 
UNESCO Clasification: 241106 Fisiología del ejercicio
Keywords: Cardiac output
VO2max
Fatigue
Performance
Issue Date: 2008
Journal: Journal of Applied Physiology 
Abstract: This study was performed to test the hypothesis that administration of recombinant human erythropoietin (rHuEpo) in humans increases maximal oxygen consumption by augmenting the maximal oxygen carrying capacity of blood. Systemic and leg oxygen delivery and oxygen uptake were studied during exercise in eight subjects before and after 13 wk of rHuEpo treatment and after isovolemic hemodilution to the same hemoglobin concentration observed before the start of rHuEpo administration. At peak exercise, leg oxygen delivery was increased from 1,777.0+/-102.0 ml/min before rHuEpo treatment to 2,079.8+/-120.7 ml/min after treatment. After hemodilution, oxygen delivery was decreased to the pretreatment value (1,710.3+/-138.1 ml/min). Fractional leg arterial oxygen extraction was unaffected at maximal exercise; hence, maximal leg oxygen uptake increased from 1,511.0+/-130.1 ml/min before treatment to 1,793.0+/-148.7 ml/min with rHuEpo and decreased after hemodilution to 1,428.0+/-111.6 ml/min. Pulmonary oxygen uptake at peak exercise increased from 3,950.0+/-160.7 before administration to 4,254.5+/-178.4 ml/min with rHuEpo and decreased to 4,059.0+/-161.1 ml/min with hemodilution (P=0.22, compared with values before rHuEpo treatment). Blood buffer capacity remained unaffected by rHuEpo treatment and hemodilution. The augmented hematocrit did not compromise peak cardiac output. In summary, in healthy humans, rHuEpo increases maximal oxygen consumption due to augmented systemic and muscular peak oxygen delivery.
URI: http://hdl.handle.net/10553/6534
ISSN: 8750-7587
DOI: 10.1152/japplphysiol.90484.2008
Source: Journal Of Applied Physiology[ISSN 8750-7587],v. 105 (2), p. 581-587
Appears in Collections:Artículos
Thumbnail
Does recombinant human Epo increase exercise capacity by means other than augmenting oxygen transport?
Adobe PDF (264,79 kB)
Show full item record

SCOPUSTM   
Citations

70
checked on Apr 4, 2020

WEB OF SCIENCETM
Citations

65
checked on Apr 4, 2020

Page view(s)

18
checked on Apr 4, 2020

Download(s)

30
checked on Apr 4, 2020

Google ScholarTM

Check

Altmetric


Share



Export metadata



This item is licensed under a Creative Commons License Creative Commons